• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,938.22 436.10
( 0.56%)
Global Indices
Nasdaq
52,909.39 583.15
(1.11%)
Dow Jones
7,503.05 -1.18
(-0.02%)
Hang Seng
68,854.54 -1,620.42
(-2.30%)
Nikkei 225
10,664.80 186.46
(1.78%)
Forex
USD-INR
94.60 0.11
(0.12%)
EUR-INR
107.91 0.13
(0.12%)
GBP-INR
125.27 0.26
(0.21%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Global Health Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
543654
INE474Q01031
149.2385834
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MEDANTA
72.93
36176.7
EPS(TTM)
Face Value()
Div & Yield %
18.45
2
0.04
 

royal india corporation ltd
Biocon consolidated net profit declines 63.45% in the March 2026 quarter
May 08,2026
Net profit of Biocon declined 63.45% to Rs 125.90 crore in the quarter ended March 2026 as against Rs 344.50 crore during the previous quarter ended March 2025. Sales rose 2.90% to Rs 4484.30 crore in the quarter ended March 2026 as against Rs 4358.10 crore during the previous quarter ended March 2025.

For the full year,net profit declined 61.95% to Rs 385.60 crore in the year ended March 2026 as against Rs 1013.30 crore during the previous year ended March 2025. Sales rose 11.48% to Rs 16779.90 crore in the year ended March 2026 as against Rs 15052.20 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4484.304358.10 3 16779.9015052.20 11
OPM %22.7524.74 -20.5921.04 -
PBDT841.30902.70 -7 2807.503477.10 -19
PBT327.90466.40 -30 850.801790.10 -52
NP125.90344.50 -63 385.601013.30 -62